Fusobacterium is a genus of filamentous, anaerobic, Gram-negative bacteria, similar to Bacteroides. Fusobacterium contribute to several human diseases, including periodontal diseases, Lemierre's syndrome, and topical skin ulcers. Although older resources have stated that Fusobacterium is a common occurrence in the human oropharynx, the current consensus is that Fusobacterium should always be treated as a pathogen.
In contrast to Bacteroides spp., Fusobacteria have a potent LPS.
F. necrophorum infection usually responds to treatment with penicillin or metronidazole, but penicillin treatment for persistent pharyngitis appears anecdotally to have a higher relapse rate, although the reasons for that are unclear. This bacterium is also considered the cause of the foot disease thrush in horses.
Although this infection is rare, researchers agree that this diagnosis should be considered in a septicaemic patient with thrombosis in an unusual site, and underlying malignancy should be excluded in cases of confirmed F. necrophorum occurring at sites caudal to the head.
F. necrophorum is also a cause for lameness in sheep. Its infection is commonly called scald. It can last for several years on land used by either sheep or cattle and is found on most land of this type throughout the world. Due to its survival length in these areas it is unrealistic to try to remove it. Sheep most often get scald due to breakage or weekness of the skin suronding the hoof. This can occur due to strong footbaths, sandy soils, mild frost byte or prolongened waterlogging of a field which results in denaturing of the skin between the cleats.
Researchers Submit Patent Application, "Detection of Fusobacterium in a Gastrointestinal Sample to Diagnose Gastrointestinal Cancer", for Approval
Oct 24, 2013; By a News Reporter-Staff News Editor at Politics & Government Week -- From Washington, D.C., VerticalNews journalists report that...
Research from Chang Gung University, Department of Internal Medicine provides new data on fusobacterium risk factors.(Report)
Feb 24, 2010; A report, 'Fusobacterium bacteremia: clinical significance and outcomes,' is newly published data in Journal of...